Radnor Capital Management’s Globus Medical GMED Stock Holding History

Radnor Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.54M	Sell	32,100 -2,000	-6%	-$170K	0.36%	71
2026 Q1	$2.94M	Sell	34,100 -40	-0.1%	-$3.59K	0.43%	53
2025 Q4	$2.98M	Buy	34,140 +1,004	+3%	+$76.2K	0.44%	54
2025 Q3	$1.9M	Buy	33,136 +320	+1%	+$18.4K	0.29%	98
2025 Q2	$1.94M	Buy	32,816 +2,555	+8%	+$165K	0.31%	88
2025 Q1	$2.21M	Buy	30,261 +1,200	+4%	+$99.2K	0.37%	68
2024 Q4	$2.4M	Sell	29,061 -910	-3%	-$71.8K	0.4%	65
2024 Q3	$2.14M	Buy	+29,971	New	+$2.12M	0.32%	82
2024 Q2	–	Sell	-29,101	Closed	-$1.56M	–	207
2024 Q1	$1.56M	Buy	29,101 +215	+0.7%	+$11.6K	0.27%	99
2023 Q4	$1.54M	Buy	28,886 +3,295	+13%	+$161K	0.29%	92
2023 Q3	$1.27M	Buy	+25,591	New	+$1.43M	0.25%	102
2023 Q2	–	Sell	-8,981	Closed	-$509K	–	175
2023 Q1	$509K	Buy	+8,981	New	+$576K	0.13%	146

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Radnor Capital Management's GMED Position: Q2 2026 in Review

Radnor Capital Management reduced its Globus Medical (GMED) stake by 5.9% in Q2 2026, selling an estimated $170K and leaving 32,100 shares worth $2.54M. The position accounts for 0.36% of the portfolio, ranked #71.

Radnor Capital Management first reported a position in GMED in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.98M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Radnor Capital Management held 32,100 shares of Globus Medical worth $2.54M as of Q2 2026.
Radnor Capital Management sold 2,000 Globus Medical shares in Q2 2026, an estimated $170K.
Globus Medical made up 0.36% of Radnor Capital Management's portfolio in Q2 2026, its #71 holding.
Radnor Capital Management first reported a position in Globus Medical in Q1 2023 and has held it in 12 quarters since.
Radnor Capital Management's Globus Medical position peaked at $2.98M in Q4 2025.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.